289 related articles for article (PubMed ID: 34002696)
1. Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia.
Aguilar JI; Cheng MH; Font J; Schwartz AC; Ledwitch K; Duran A; Mabry SJ; Belovich AN; Zhu Y; Carter AM; Shi L; Kurian MA; Fenollar-Ferrer C; Meiler J; Ryan RM; Mchaourab HS; Bahar I; Matthies HJ; Galli A
Elife; 2021 May; 10():. PubMed ID: 34002696
[TBL] [Abstract][Full Text] [Related]
2. Pharmacochaperoning in a
Asjad HMM; Kasture A; El-Kasaby A; Sackel M; Hummel T; Freissmuth M; Sucic S
J Biol Chem; 2017 Nov; 292(47):19250-19265. PubMed ID: 28972153
[TBL] [Abstract][Full Text] [Related]
3. Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in
Campbell NG; Shekar A; Aguilar JI; Peng D; Navratna V; Yang D; Morley AN; Duran AM; Galli G; O'Grady B; Ramachandran R; Sutcliffe JS; Sitte HH; Erreger K; Meiler J; Stockner T; Bellan LM; Matthies HJG; Gouaux E; Mchaourab HS; Galli A
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3853-3862. PubMed ID: 30755521
[TBL] [Abstract][Full Text] [Related]
4. Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease.
Herborg F; Jensen KL; Tolstoy S; Arends NV; Posselt LP; Shekar A; Aguilar JI; Lund VK; Erreger K; Rickhag M; Lycas MD; Lonsdale MN; Rahbek-Clemmensen T; Sørensen AT; Newman AH; Løkkegaard A; Kjærulff O; Werge T; ; Møller LB; Matthies HJ; Galli A; Hjermind LE; Gether U
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34375312
[TBL] [Abstract][Full Text] [Related]
5. Latch and trigger role for R445 in DAT transport explains molecular basis of DTDS.
Reith MEA; Jones KT; Zhen J; Topiol S
Bioorg Med Chem Lett; 2018 Feb; 28(3):470-475. PubMed ID: 29258773
[TBL] [Abstract][Full Text] [Related]
6. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder.
Hamilton PJ; Campbell NG; Sharma S; Erreger K; Herborg Hansen F; Saunders C; Belovich AN; ; Sahai MA; Cook EH; Gether U; McHaourab HS; Matthies HJ; Sutcliffe JS; Galli A
Mol Psychiatry; 2013 Dec; 18(12):1315-23. PubMed ID: 23979605
[TBL] [Abstract][Full Text] [Related]
7. A Caenorhabditis elegans model to study dopamine transporter deficiency syndrome.
Illiano P; Lanzo A; Leo D; Paglione M; Zampi G; Gainetdinov RR; Di Schiavi E
Eur J Neurosci; 2017 Jan; 45(1):207-214. PubMed ID: 27519790
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells.
Beerepoot P; Lam VM; Salahpour A
J Biol Chem; 2016 Oct; 291(42):22053-22062. PubMed ID: 27555326
[TBL] [Abstract][Full Text] [Related]
9. SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.
Bowton E; Saunders C; Reddy IA; Campbell NG; Hamilton PJ; Henry LK; Coon H; Sakrikar D; Veenstra-VanderWeele JM; Blakely RD; Sutcliffe J; Matthies HJ; Erreger K; Galli A
Transl Psychiatry; 2014 Oct; 4(10):e464. PubMed ID: 25313507
[TBL] [Abstract][Full Text] [Related]
10. Homozygous in-frame variant of SCL6A3 causes dopamine transporter deficiency syndrome in a consanguineous family.
Heidari E; Razmara E; Hosseinpour S; Tavasoli AR; Garshasbi M
Ann Hum Genet; 2020 Jul; 84(4):315-323. PubMed ID: 32077500
[TBL] [Abstract][Full Text] [Related]
11. Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors.
DiCarlo GE; Aguilar JI; Matthies HJ; Harrison FE; Bundschuh KE; West A; Hashemi P; Herborg F; Rickhag M; Chen H; Gether U; Wallace MT; Galli A
J Clin Invest; 2019 May; 129(8):3407-3419. PubMed ID: 31094705
[TBL] [Abstract][Full Text] [Related]
12. Anomalous dopamine release associated with a human dopamine transporter coding variant.
Mazei-Robison MS; Bowton E; Holy M; Schmudermaier M; Freissmuth M; Sitte HH; Galli A; Blakely RD
J Neurosci; 2008 Jul; 28(28):7040-6. PubMed ID: 18614672
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport.
Quizon PM; Sun WL; Yuan Y; Midde NM; Zhan CG; Zhu J
Sci Rep; 2016 Dec; 6():39048. PubMed ID: 27966610
[TBL] [Abstract][Full Text] [Related]
14. An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.
Fraser R; Chen Y; Guptaroy B; Luderman KD; Stokes SL; Beg A; DeFelice LJ; Gnegy ME
Mol Pharmacol; 2014 Jul; 86(1):76-85. PubMed ID: 24753048
[TBL] [Abstract][Full Text] [Related]
15. Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport.
Midde NM; Yuan Y; Quizon PM; Sun WL; Huang X; Zhan CG; Zhu J
J Neuroimmune Pharmacol; 2015 Mar; 10(1):122-35. PubMed ID: 25604666
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism.
Ng J; Barral S; De La Fuente Barrigon C; Lignani G; Erdem FA; Wallings R; Privolizzi R; Rossignoli G; Alrashidi H; Heasman S; Meyer E; Ngoh A; Pope S; Karda R; Perocheau D; Baruteau J; Suff N; Antinao Diaz J; Schorge S; Vowles J; Marshall LR; Cowley SA; Sucic S; Freissmuth M; Counsell JR; Wade-Martins R; Heales SJR; Rahim AA; Bencze M; Waddington SN; Kurian MA
Sci Transl Med; 2021 May; 13(594):. PubMed ID: 34011628
[TBL] [Abstract][Full Text] [Related]
17. Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson's disease (PD) - A road to discovery?
Jayaramayya K; Iyer M; Venkatesan D; Balasubramanian V; Narayanasamy A; Subramaniam MD; Cho SG; Vellingiri B
Brain Res Bull; 2020 Apr; 157():169-179. PubMed ID: 32035946
[TBL] [Abstract][Full Text] [Related]
18. Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood.
Ng J; Zhen J; Meyer E; Erreger K; Li Y; Kakar N; Ahmad J; Thiele H; Kubisch C; Rider NL; Morton DH; Strauss KA; Puffenberger EG; D'Agnano D; Anikster Y; Carducci C; Hyland K; Rotstein M; Leuzzi V; Borck G; Reith ME; Kurian MA
Brain; 2014 Apr; 137(Pt 4):1107-19. PubMed ID: 24613933
[TBL] [Abstract][Full Text] [Related]
19. Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions.
Midde NM; Huang X; Gomez AM; Booze RM; Zhan CG; Zhu J
J Neuroimmune Pharmacol; 2013 Sep; 8(4):975-87. PubMed ID: 23645138
[TBL] [Abstract][Full Text] [Related]
20. Functional Rescue of a Misfolded
Kasture A; El-Kasaby A; Szöllősi D; Asjad HMM; Grimm A; Stockner T; Hummel T; Freissmuth M; Sucic S
J Biol Chem; 2016 Sep; 291(40):20876-20890. PubMed ID: 27481941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
